Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston blog main
boston top stories
cancer
5
×
investing
5
×
ipo
5
×
life sciences
national blog main
national top stories
new york blog main
new york top stories
san francisco blog main
san francisco top stories
boulder/denver blog main
boulder/denver top stories
cancer immunotherapy
clinical trials
deals
detroit blog main
detroit top stories
fda
indiana blog main
indiana top stories
national
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
sanofi
seattle blog main
seattle top stories
takeda pharmaceutical
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
alexion pharmaceuticals
cancer drugs
eli lilly
novartis
What
ipo
bio
companies
drug
latest
life
medicines
new
pharmaceutical
roundup
science
typically
alzheimer’s
bails
biotechs
brand
bridgebio
cancer
capital
car
club
company’s
continued
course
crop
despite
develop
development
different
discover
drugs
emerges
exceeded
experimental
fail
family
firm
firms
gene
grab
Language
unset
Current search:
ipo
×
cancer
×
investing
×
@xconomy.com
4 years ago
Revolution Medicines IPO Reels In $238M to Take On RAS in Cancer
@xconomy.com
4 years ago
Schrödinger Sets Course for IPO to Support Growing Internal Pipeline
@xconomy.com
4 years ago
Bio Roundup: Ichnos Emerges, Beyond CAR-T, BridgeBio Bails & More
@xconomy.com
5 years ago
Bio Roundup: Alzheimer’s Fail, Drug Price Plan, Gene Therapies & More
@xconomy.com
5 years ago
IPO Wave Rolls On as Five Life Science Firms Haul in $651M